Best of SABCS® Canada Conference 2025

Friday, February 7, 2025
Event Type:
Hybrid

Conference Venue: Chelsea Hotel, Toronto

Event Landscape

The Best of SABCS® 2025 will provide a comprehensive overview of the cutting-edge advancements in breast cancer treatment that were highlighted at the San Antonio Breast Cancer Symposium. Join Dr. Christine Brezden-Masley and Dr. David Cescon to receive a thorough analysis of the most impactful research and emerging trends. The event will feature presentations from leading experts in the field, providing in-depth analysis and discussion on the latest research. The aim is to enhance the current standards of cancer care by integrating these cutting-edge developments into Canadian practices.

Learning Objectives

  1. Describe key clinical trial data from 2024 in the management of breast cancer and understand the impact on Canadian practices.
  2. Understand the latest strategies in breast cancer pathology, radiation, and surgery.
  3. Implement approaches that maximize patient standard of care in breast cancer.

Scientific Agenda

Click below to learn more about the scheduled presentations and incredible speaker lineup

Event Co-Chairs

Dr. Brezden-Masley

Dr. Christine Brezden-Masley
MD, PhD, FRCPC

Christine Brezden-Masley, MD PhD FRCPC is a senior practicing Medical Oncologist and the Medical Director of the Cancer Program at Sinai Health System in Toronto, Canada. She is also the Director of the Marvelle Koffler Breast Centre at Sinai Health and holds the Marvelle Koffler Chair in Breast Research. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the Temerty Faculty of Medicine, University of Toronto and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is the Past-President of the Canadian Cardio-Oncology Network (2017-2022). She also serves on the International Cardio-Oncology Society (ICOS) annual summit steering committees and co-chaired the 2022 Global Cardio-Oncology Summit in Toronto. She co-chairs the Junior Mentoring Program JuMP that fosters mentorship/sponsorship of junior medical oncology faculty across Canada and serves on the executive of WinC (Women in Cancer/All in Cancer). She is an advocate for patients and serves as a board member of ReThink Breast Cancer and MyGutFeeling and also serves on the scientific committee for the Colorectal Cancer Resource & Action Network.

Dr. Dave Cescon

Dr. Dave Cescon
MD, PhD, FRCPC

Dr. David Cescon is a breast medical oncologist and clinician scientist at Princess Margaret Cancer Centre in Toronto. His clinical and academic interests include drug and biomarker development, and the application of circulating tumour DNA technologies in breast cancer. He is a member of multiple international breast cancer clinical trial initiatives and is the incoming chair of the Canadian Cancer Trials Group IND program.

Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Bernadette Gregoris at [email protected]. Industry registrations will not be accepted through the website.

Sponsorship

​For sponsorship-related inquiries, please contact Bernadette Gregoris at [email protected].

Event Sponsors

Platinum sponsors

Beigene logo

Silver sponsors

Bronze sponsors

All sales are final, refunds will not be accepted.
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.

Register Now